Independent review of Stage 1 and Stage 2 hormone therapies in Queensland’s public paediatric gender services
On 28 January 2025, the Queensland Government announced an independent review of the evidence for using puberty suppression (Stage 1) and gender-affirming (Stage 2) hormone therapies in Queensland’s public paediatric gender services.
It will examine the quality and outcomes of available medical and clinical evidence, as well as ethical considerations to inform government policy.
A final report will be provided to the Director-General of Queensland Health by 30 November 2025.
Stakeholder submissions
Stakeholders will have the opportunity to make a submission to the review. Information on how they can do so will be published here when the submissions process is finalised.